Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.35 |
| ▸ | FAP | Q12884 | 11/20 | 0.33 |
| ▸ | PREP | P48147 | 1/20 | 0.32 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.32 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.32 |
| ▸ | ITGAV | P06756 | 1/20 | 0.32 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.32 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14212747 | 0.95 | FAP (0.33) | FAPPREP | |
| SCHEMBL16489111 | 0.78 | MYC (0.34) | MEN1KMT2A | |
| SCHEMBL14681719 | 0.76 | LMNA (0.35) | MEN1KMT2A | |
| SCHEMBL15290195 | 0.74 | FAP (0.34) | ACEFAPPREP | |
| SCHEMBL25207239 | 0.72 | MYC (0.35) | MEN1KMT2A | |
| SCHEMBL15290194 | 0.69 | FAP (0.34) | FAPPREP | |
| SCHEMBL14870371 | 0.66 | GAA (0.34) | MEN1KMT2A | |
| SCHEMBL12302213 | 0.64 | TSHR (0.36) | MEN1KMT2A | |
| SCHEMBL25266487 | 0.64 | MYC (0.34) | MEN1KMT2A | |
| SCHEMBL17399551 | 0.63 | HTT (0.32) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120309045-A1 | Composite Probes and Use Thereof in Super Resolution Methods | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2012-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309045-A1 | Composite Probes and Use Thereof in Super Resolution Methods | BLM, SFPQ, RAD51 | ACE 4373/4885FAP 1455/4885PREP 3428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.